Highly Potent

Feb 16, 2017
By Pharmaceutical Technology Editors
The new commercial site, set to be located in Cambridge, Boston, MA, will serve clients on both the East and West Coast. It will also be the base for reaching new customers in the area.
Nov 08, 2016
By Pharmaceutical Technology Editors
Idifarma has announced a growth of more than 50% over the past two years. Revenue is expected to hit approximately EUR5.3 million in 2016, growing from EUR3.5 million in 2014.
Sep 22, 2016
By Pharmaceutical Technology Editors
PCI will be participating in two Speakers Corner slots at the ICSE Exhibitor Showcase.
Aug 18, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
CDMO Alcami adds HPAPI capacity and cryogenic capabilities to its Wisconsin facility.
Aug 16, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Piramal Enterprises has entered into an agreement to acquire 100% stake in Ash Stevens all by cash for a consideration of $42.95 million plus an earn-out consideration capped at $10 million.
Aug 02, 2016
Pharmaceutical Technology
The design of Baxter BioPharma Solutions’ aseptic filling lines provides a case study in customizing containment systems for multi-product lines
Jul 26, 2016
By Pharmaceutical Technology Editors
The project involves installation of a small-scale pressured agitated nutsche filter dryer in glass, integrated in a high-containment isolator to achieve an occupational exposure limit of less than 1 microgram per meter cube, 8-hour time weighted average.
Jun 16, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Hovione expands drug substance and HPAPI capacity in East Windsor, New Jersey.
May 16, 2016
By Pharmaceutical Technology Editors
Combining powder micro-dosing services with the Xcelodose technology, Capsugel offers capabilities in both North America and Europe.
May 04, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
The production of antibody-drug conjugates requires biopharmaceutical and chemical manufacturing, and conjugation capabilities.
native1_300x100
lorem ipsum